Skip to main content
Equibles

John C. Reed

Board Member

Madrigal Pharmaceuticals, Inc. (MDGL)

Equibles does not estimate personal net worth.

Get an email with a short summary when Madrigal Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get MDGL alerts

About John C. Reed

John C. Reed is recorded as Board Member at Madrigal Pharmaceuticals, Inc. (MDGL) since August 11, 2026. Madrigal Pharmaceuticals, Inc. reported in an 8-K filed August 12, 2026 that John C. Reed was appointed Class II director, effective August 11, 2026. Madrigal Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Madrigal Pharmaceuticals, Inc. includes Bill Sibold (CEO and Board Member), Julian C. Baker (Chairman and Board Member), Mardi Dier (CFO) and 7 others.

“On August 11, 2026, the Board of Directors (the "Board") of Madrigal Pharmaceuticals, Inc. (the "Company") expanded the size of the Board from eight to nine members and, following the recommendation of its Nominating and Governance Committee, elected John C. Reed, M.D., Ph.D. to fill the newly created vacancy on the Board effective as of August 11, 2026.”
Madrigal Pharmaceuticals, Inc. Form 8-K, filed August 12, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Madrigal Pharmaceuticals, Inc.

Recent activity